Patent Foramen Ovale Closure: British Cardiovascular Intervention Society Position Statement

Mark Turner1, Suneil K Aggarwal2, Michael J Mullen2

  • 1Department of Cardiology, Bristol Heart Institute, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust Bristol, UK.

Insights

A patent foramen ovale (PFO) is a flap in the heart that may not fully close after birth. This statement outlines PFO diagnosis, closure indications, and procedures.

Area of Science:

  • Cardiovascular Science
  • Medical Interventions
  • Congenital Heart Conditions

Background:

  • The foramen ovale is a fetal structure allowing placental blood flow to the systemic circulation.
  • In 25% of individuals, the foramen ovale (specifically the primum septal flap) does not fully seal after birth, resulting in a patent foramen ovale (PFO).
  • Most PFOs are small, with shunting occurring primarily during Valsalva maneuvers; resting right-to-left shunts are less common (5% of individuals).

Purpose of the Study:

  • To provide a position statement on the diagnosis of patent foramen ovale (PFO).
  • To outline the indications for PFO closure.
  • To describe the procedural aspects of PFO closure.

Main Methods:

  • This document represents a position statement from the British Cardiovascular Intervention Society.
  • It synthesizes current knowledge and expert opinion on PFO management.
  • The statement details diagnostic modalities and interventional techniques for PFO closure.

Main Results:

  • The document addresses the prevalence and functional significance of PFO.
  • It delineates specific clinical scenarios warranting PFO closure.
  • Guidance is provided on the technical aspects and best practices for PFO closure procedures.

Conclusions:

  • Patent foramen ovale is a common condition with varying degrees of clinical relevance.
  • Timely diagnosis and appropriate patient selection are crucial for successful PFO closure.
  • This position statement serves as a guide for clinicians managing patients with PFO.

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
422
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598